Subclass opioid receptors associated with the cardiovascolar depression after traumatic shock and the antishock effects of its specific receptor antagonists

Shock

Volumn 24, Issue 5, 2005, Pages 470-475

  Liu, Liang Ming ^a   Hu, De Yao ^a   Pan, Xue Kun ^a   Lu, Ru Quan ^a   Dan, Fei Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular function; Opioid receptor antagonist; Opioid receptors; Shock; Traumatic

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ETORPHINE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTREXONE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BRAIN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMUR FRACTURE; HEART; HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NONHUMAN; PAIN THRESHOLD; RAT; SURVIVAL; TRAUMATIC SHOCK;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ENKEPHALIN, LEUCINE; FEMUR; FREE RADICALS; GABA MODULATORS; HEMODYNAMIC PROCESSES; MODELS, STATISTICAL; NALTREXONE; NARCOTIC ANTAGONISTS; PENTOBARBITAL; RATS; RATS, WISTAR; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SHOCK; TIME FACTORS;

EID: 27644464324     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000183432.17092.34     Document Type: Article

References (37)

1. Bellamy RF: The cause of death in conventional land warfare: implication for combat casualty care research. Milit Med 149:55-62, 1984.
2. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A: A profile of combat injury. J Trauma 54:S13-S19, 2003.
3. Champion HR: Combat fluid resuscitation and overview of conferences. J Trauma 54:S7-S12, 2003.
4. Nolan J: Fluid resuscitation for the trauma patient. Resuscitation 48:57-69, 2001.
5. Horton JW. White J, Maass D, Sanders B, Thompson M, Girroir B: Calcium antagonists improve cardiac mechanical performance after thermal trauma. J Surg Res 87:39-50, 1999.
6. Büttemeyer RA, Schlenzka PW, Mall LJ: Epigallocatechin gallate can significantly decrease free oxygen radicals in the reperfusion injury in vivo. Transpl Proc 35:3116-3120, 2003.
7. Bergman M, Perelman A, Dubinsky Z, Grossman S: Scavenging of reactive oxygen species by a novel glucuronated flavonoid antioxidant isolated and purified from spinach. Phytochemistry 62:753-762, 2003.
8. Chamberlain JM, Klein BL: A comprehensive review of naloxone for the emergency physician. Am Emerg Med 12:650-660, 1994.
9. Akin MZ, Tuncel N. Gurer F, Kural N, Uslu S: Effects of vasoactive intestinal peptide and naloxone combination on urinary N-acetyl-β-D- glucosaminidase level and kidney histology of rats exposed to severe hemorrhage. Pharmacology 47:194-199, 1993.
10. Greeneltch KM, Haudenschild CC, Keegan AD, Shi YF: The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-α production. Brain Behav Immun 18:476-484, 2004.
11. Lu W, Fang ZY, Chen WL: Endogenous opioid peptides and shock. Essential Problem of Trauma Surg 15:196-200, 1994.
12. D'Amato R, Holaday JW: Multiple opioid receptors in endotoxic shock: evidence for 8 involvement and μ-δ interactions in vivo. Proc Natl Acad Sci USA 81:2898-2901, 1984.
13. Romano FD, Jones SB: Alteration in β-adrenergic stimulation of myocardial adenylate cyclase in endotoxic rats. Am J Physiol 250:358-364, 1986.
14. Liu LM, Chen HS, Hu DY, Lu RQ: Effects of thyrotropin-releasing hormone on myocardial adrenoceptors and dopaminergic receptors following hemorrhagic shock in the rat. Shock 3:430-433, 1995.
15. Liu LM, Hu DY, Chen HS, Lu RQ: The importance of δ and κ opioid receptors on the property of TRH against hemorrhagic shock. Shock 7:60-64, 1997.
16. Seedat S, Stein DJ, Carey PD: Post-traumatic stress disorder in women: epidemiological and treatment issues. CNS Drugs 19:411-427, 2005.
17. Nicholson G, Woodfine J, Bryant AE, Macdonald IA, Bircher MD, Grounds RM, Hall GM: The hormonal and inflammatory responses to pelvic reconstructive surgery following major trauma. Injury 36:303-309, 2005.
18. Monila PE: Endogenous opioid analgesia in hemorrhagic shock. J Trauma 54:5126-5132, 2003.
19. Monila PE: Stress-specific opioid modulation of hemodynamic counter-regulation. Clin Exp Pharmacol Physiol 29:248-253, 2002.
20. Molina PE: Opiate modulation of hemodynamic, hormonal, and cytokine responses to hemorrhage. Shock 15:471-478, 2001.
21. 2+]I in rat arterial smooth muscle cells in hemorrhagic shock. Acta Pharmacol Sin 25:395-400, 2004.
22. + channels in mesenteric arterial smooth muscle cells of rats in hemorrhagic shock. Shock 19:85-90, 2003.
23. Pugsley MK: The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 93:51-75, 2002.
24. Mao L, Wang JQ: Cardiovascular responses to microinjection of nociceptin and endomorphin-1 into the nucleus tractus solitarii in conscious rats. Neuroscience 132:1009-1015, 2005.
25. Bodnar RJ, Klein GE: Endogenous opiates and behavior: 2003. Peptides 25:2205-2256, 2004.
26. Bodnar RJ, Hadjimmarkou MM: Endogenous opiates and behavior: 2002. Peptides 24:1241-1302, 2003.
27. Loodbrook J, Ventura S: The decompensatory phase of acute hypovolemia in rabbits involves a central δ1-opioid receptor. Eur J Pharmacol 2:113-116, 1994.
28. Henderson LA, Keay KA, Bandler R: δ- and κ-opioid receptors in the caudal midline medulla mediate hemorrhage-evoked hypotension. Neuroreport 13:729-733, 2002.
29. Baker CH, Sutton ET, Zhon Z, Reynolds DG: Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock. Circ Shock 32:101-112, 1990.
30. Xu Te: The mechanisms of endogenous opioid peptides in the pathogenesis of endotoxic and cardiogenic shock. Prog Physiol Sci 24:248-251, 1993.
31. Liu LM, Li P, Diao YF, Zhou XW, Zhou R, Liao ZF, Tian KL, Liu JC: Changes in systemic and local vascular reactivity in hemorrhagic shock and the therapeutic effect of 5 opioid receptor antagonist ICI174,864. Chin Crit Care Med 17:16-19, 2005.
32. Odeh M: Tumor necrosis factor-α as a myocardial depressant substance. Int J Cardiol 42:231-238, 1993.
33. Roy S, Charmoneau RG, Barke RA: Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J Neuroimmunol 95:107-114, 1999.
34. Van der Poll T, Lowry SF: Tumor necrosis in sepsis: mediator of multiple organ failure or essential part of host defense. Shock 3:1-12, 1995.
35. Tian KL, Liu LM, Lu RQ: Beneficial effects of ICI174,864 on traumatic shock in rats and its relationship with adrenal medulla. J Trauma Surg 5:52-55, 2003.
36. Kai L, Hu DY, Wang ZF, Shi YL, Liu LM: Modulation of opioid receptors on vascular hyperactivity of rats after hemorrhagic shock. Acta Acad Med Milit Tert 24:1185-1188, 2002.
37. Liu LM, Hu DY, Chen HS, Lu RQ: Effects of ICI174,864, Nor-binaltorphimine on hemodynamic following hypovolemic shock in rabbits. Modern Appl Pharmacol 13:1-4, 1996.